DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

H.C. Wainwright Maintains Buy on Krystal Biotech, Raises Price Target to $68

H.C. Wainwright analyst Joseph Pantginis maintains Krystal Biotech (NASDAQ: KRYS) with a Buy and raises the price target from $59 to $68.

Benzinga · 03/10/2020 16:48

H.C. Wainwright analyst Joseph Pantginis maintains Krystal Biotech (NASDAQ: KRYS) with a Buy and raises the price target from $59 to $68.